Less Effect of Intranasal Than Oral Hormone Therapy on Factors Associated With Venous Thrombosis Risk in Healthy Postmenopausal Women

@article{Hemelaar2006LessEO,
  title={Less Effect of Intranasal Than Oral Hormone Therapy on Factors Associated With Venous Thrombosis Risk in Healthy Postmenopausal Women},
  author={M. Hemelaar and J. Rosing and P. Kenemans and M. Thomassen and D. Braat and M. J. van der Mooren},
  journal={Arteriosclerosis, Thrombosis, and Vascular Biology},
  year={2006},
  volume={26},
  pages={1660-1666}
}
Objective—To compare the effects of intranasal and oral administration of 17&bgr;-estradiol (E2) and norethisterone(acetate) [NET(A)] in healthy postmenopausal women on activated protein C (APC) resistance and other hemostatic parameters associated with venous thrombosis. Methods and Results—In this 2-center, randomized, double-blind, 1-year trial, 90 postmenopausal women (56.6±4.7 years of age) received daily either an intranasal spray with 175 &mgr;g/275 &mgr;g E2/NET (n=47) or 1 mg/0.5 mg… Expand
Effects of ultra-low-dose versus standard hormone therapy on fibrinolysis and thrombin generation in postmenopausal women.
Prevention and treatment of venous thromboembolism during HRT: current perspectives
  • H. Rott
  • Medicine
  • International journal of general medicine
  • 2014
...
1
2
...

References

SHOWING 1-10 OF 39 REFERENCES
Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms.
...
1
2
3
4
...